Nuvama downgraded Voltas citing weak near-term demand and high inventory, while Kotak sees improvement in SBI Cards’ asset quality and spending. CLSA expects Dalmia Bharat’s volumes to rise but margins to be pressured by weak pricing. Morgan Stanley views HCL Tech’s acquisition as financially minor, and Citigroup remains positive on Divis Laboratories amid global supply chain shifts.